Annual Revenue
$138.39 M
-$19.36 M-12.27%
December 31, 2024
Summary
- As of March 9, 2025, ARCT annual revenue is $138.39 million, with the most recent change of -$19.36 million (-12.27%) on December 31, 2024.
- During the last 3 years, ARCT annual revenue has risen by +$126.03 million (+1019.74%).
- ARCT annual revenue is now -32.74% below its all-time high of $205.75 million, reached on December 31, 2022.
Performance
ARCT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$21.00 M
-$17.82 M-45.90%
December 31, 2024
Summary
- As of March 9, 2025, ARCT quarterly revenue is $21.00 million, with the most recent change of -$17.82 million (-45.90%) on December 31, 2024.
- Over the past year, ARCT quarterly revenue has dropped by -$24.98 million (-54.32%).
- ARCT quarterly revenue is now -86.88% below its all-time high of $160.05 million, reached on December 31, 2022.
Performance
ARCT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$138.39 M
-$4.08 M-2.86%
December 31, 2024
Summary
- As of March 9, 2025, ARCT TTM revenue is $138.39 million, with the most recent change of -$4.08 million (-2.86%) on December 31, 2024.
- Over the past year, ARCT TTM revenue has dropped by -$8.64 million (-5.88%).
- ARCT TTM revenue is now -52.72% below its all-time high of $292.72 million, reached on September 30, 2023.
Performance
ARCT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ARCT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.3% | -54.3% | -5.9% |
| 3 y3 years | +1019.7% | +57.1% | +168.7% |
| 5 y5 years | +565.7% | +57.1% | +168.7% |
ARCT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.7% | +1019.7% | -86.9% | +300.5% | -52.7% | +1019.7% |
| 5 y | 5-year | -32.7% | +1350.8% | -86.9% | +949.5% | -52.7% | +1490.9% |
| alltime | all time | -32.7% | +2154.6% | -86.9% | +949.5% | -52.7% | +2154.6% |
Arcturus Therapeutics Holdings Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $138.39 M(-12.3%) | $21.00 M(-45.9%) | $138.39 M(-2.9%) |
| Sep 2024 | - | $38.81 M(-15.6%) | $142.47 M(-3.1%) |
| Jun 2024 | - | $45.98 M(+41.0%) | $147.03 M(+32.9%) |
| Mar 2024 | - | $32.60 M(+30.0%) | $110.62 M(-29.9%) |
| Dec 2023 | $157.75 M(-23.3%) | $25.08 M(-42.2%) | $157.75 M(-46.1%) |
| Sep 2023 | - | $43.38 M(+353.5%) | $292.72 M(+11.4%) |
| Jun 2023 | - | $9.56 M(-88.0%) | $262.71 M(-6.3%) |
| Mar 2023 | - | $79.73 M(-50.2%) | $280.24 M(+36.2%) |
| Dec 2022 | $205.75 M(+1564.8%) | $160.05 M(+1097.2%) | $205.75 M(+299.5%) |
| Sep 2022 | - | $13.37 M(-50.7%) | $51.50 M(+26.9%) |
| Jun 2022 | - | $27.09 M(+416.6%) | $40.57 M(+162.1%) |
| Mar 2022 | - | $5.24 M(-9.5%) | $15.48 M(+25.2%) |
| Dec 2021 | $12.36 M(+29.6%) | $5.79 M(+137.8%) | $12.36 M(+40.4%) |
| Sep 2021 | - | $2.44 M(+21.8%) | $8.80 M(+1.2%) |
| Jun 2021 | - | $2.00 M(-5.9%) | $8.70 M(-3.6%) |
| Mar 2021 | - | $2.13 M(-5.0%) | $9.02 M(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $9.54 M(-54.1%) | $2.24 M(-4.1%) | $9.54 M(-7.1%) |
| Sep 2020 | - | $2.33 M(+0.5%) | $10.27 M(-8.8%) |
| Jun 2020 | - | $2.32 M(-12.2%) | $11.25 M(-41.0%) |
| Mar 2020 | - | $2.65 M(-10.8%) | $19.09 M(-8.2%) |
| Dec 2019 | $20.79 M(+32.0%) | $2.97 M(-10.5%) | $20.79 M(-18.1%) |
| Sep 2019 | - | $3.32 M(-67.3%) | $25.40 M(-0.4%) |
| Jun 2019 | - | $10.15 M(+133.4%) | $25.50 M(+43.8%) |
| Mar 2019 | - | $4.35 M(-42.6%) | $17.74 M(+12.6%) |
| Dec 2018 | $15.75 M(+21.2%) | $7.58 M(+121.4%) | $15.75 M(+54.5%) |
| Sep 2018 | - | $3.42 M(+43.5%) | $10.20 M(+1.3%) |
| Jun 2018 | - | $2.39 M(+0.8%) | $10.07 M(-12.0%) |
| Mar 2018 | - | $2.37 M(+17.2%) | $11.44 M(+26.1%) |
| Dec 2017 | $13.00 M(-36.2%) | $2.02 M(-38.7%) | $9.08 M(-66.9%) |
| Sep 2017 | - | $3.30 M(-12.4%) | $27.44 M(+13.7%) |
| Jun 2017 | - | $3.76 M(-81.5%) | $24.14 M(+18.5%) |
| Dec 2016 | $20.38 M(+232.1%) | $20.38 M(+232.1%) | $20.38 M(+232.1%) |
| Dec 2015 | $6.14 M | $6.14 M | $6.14 M |
FAQ
- What is Arcturus Therapeutics Holdings annual revenue?
- What is the all time high annual revenue for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual revenue year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly revenue?
- What is the all time high quarterly revenue for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly revenue year-on-year change?
- What is Arcturus Therapeutics Holdings TTM revenue?
- What is the all time high TTM revenue for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM revenue year-on-year change?
What is Arcturus Therapeutics Holdings annual revenue?
The current annual revenue of ARCT is $138.39 M
What is the all time high annual revenue for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual revenue is $205.75 M
What is Arcturus Therapeutics Holdings annual revenue year-on-year change?
Over the past year, ARCT annual revenue has changed by -$19.36 M (-12.27%)
What is Arcturus Therapeutics Holdings quarterly revenue?
The current quarterly revenue of ARCT is $21.00 M
What is the all time high quarterly revenue for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly revenue is $160.05 M
What is Arcturus Therapeutics Holdings quarterly revenue year-on-year change?
Over the past year, ARCT quarterly revenue has changed by -$24.98 M (-54.32%)
What is Arcturus Therapeutics Holdings TTM revenue?
The current TTM revenue of ARCT is $138.39 M
What is the all time high TTM revenue for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM revenue is $292.72 M
What is Arcturus Therapeutics Holdings TTM revenue year-on-year change?
Over the past year, ARCT TTM revenue has changed by -$8.64 M (-5.88%)